Skip to content

Immersive Multimedia as an Adjunctive Measure for Pain Control in Cancer Patients

CompletedNot applicableNCT02995434
View the official record on ClinicalTrials.gov

Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.

Brief summary (from the registry)

This study seeks to explore the efficacy of immersive multimedia experiences as a practical adjunctive therapeutic intervention in the self-management of the chronic pain associated with cancer patients. A comparative controlled interventional trial and qualitative interpretative-descriptive exploration will be undertaken with 100 cancer patients who are experiencing chronic pain. Participants will be randomly assigned to either a virtual reality (VR) therapy group or a 2D computer based multimedia control group (50 subjects in each). They will undertake either a series of VR interventions, or 2D computer based multimedia control sessions in their own homes over a period of a month. The intervention will be used daily for a month to enable customization to the therapy and record data over a long enough period of time to account for any individual short-term changes in pain. The VR sessions will consist of using a VR head mounted display (HMD) and computer to explore interactive immersive environments. The control group will be exposed to similar 2D computer based multimedia experiences (without a VR headset) that on home computers. Pre, during, and post pain test scores and quality of sleep assessments will be recorded using standardized tools. In addition to the primary study, a sub-study will be conducted where ten of the subjects who demonstrated the most improvement in their pain using the VR experience will be selected and invited to explore for any measurable changes in neurological activity using pre and post exposure electroencephalography (EEG).

Study details

Official title
Immersive Multimedia as an Adjunctive Measure for Pain Control in Cancer Patients
Interventions
  • Device: Virtual Reality Headset
  • Other: 2D PC
Sponsor
University of British Columbia
Collaborators
Lotte & John Hecht Memorial Foundation; Simon Fraser University; Fraser Health
Start date
2017-07-31
Primary completion
2022-12-31
Sex
All
Age range
from 16 Years
Healthy volunteers
true
Results posted
Yes, on ClinicalTrials.gov
Countries
Canada
Total sites listed
3

Eligibility criteria

Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Age 16 or older * Previous or current medical diagnosis of cancer * Previous or current treatment by chemotherapy, radiotherapy, hormonal * Currently an outpatient (not hospitalized) * Chronic pain sufferer (suffering ongoing daily pain for 3 months or more with a Neuropathic Rating Pain Scale score of 4 or more) * Able to understand the English language, and read and write English * Have normal stereoscopic (binocular) vision * Able to easily move your head up, down, left and right and wear a headset * Have fine motor control in one hand sufficient to operate a joystick/control * Have space at home for a computer and monitor equipment Exclusion Criteria: * Cognitive impairment/inability to control a basic computer VR interface, or complete questionnaires * Receiving regular non-pharmacological pain relieving adjunct therapies for the management of chronic pain * Susceptibility to motion sickness/cyber-sickness * Susceptibility to claustrophobia (fear of confined places) * History of susceptibility to seizures

Canadian sites (3)

FacilityCityProvince
Simon Fraser University - School of Interactive Arts and TechnologySurreyBritish Columbia
BC CancerVancouverBritish Columbia
University of British Columbia - School of NursingVancouverBritish Columbia
Canadian sites for NCT02995434SurreyVancouver
Canadian sites for NCT02995434. 2 mapped locations with coordinates in the registry. Schematic plot, not to scale.

Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT02995434